Recombinant Human S100A8 Protein, CF Summary
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
|Formulation||Lyophilized from a 0.2 μm filtered solution in Tris and TCEP with Trehalose.|
|Reconstitution||Reconstitute at 150 μg/mL in water.|
|Shipping||The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.|
|Stability & Storage:||
Recombinant Human S100A8 (Catalog # 9876-S8) induces CXCL1/KC secretion in C3H10T1/2 mouse embryonic fibroblast cells. The ED50for this effect is 4-20 μg/mL.
S100A8 (also known as MRP8 and calgranulin A) is a 10 kDa member of the S100 family, EF-hand superfamily of Ca2+ binding proteins (1, 2). It is produced by neutrophils and monocytes, and forms Ca2+ dependent heterodimer/ heterotetramer complexes (termed calprotectin) with S100A9 in addition to forming homodimeric complexes. Like S100A9, S100A8 is up-regulated in neutrophils and monocytes at sites of inflammation (e.g. psoriasis, rheumatoid arthritis, cardiac ischemia) and is present at elevated concentrations in rheumatoid arthritis synovial fluid (3-5). It functions both intracellularly and extracellularly, where it binds to RAGE and CD36. In addition, S100A8 was shown to activate lung alveolar epithelial cells, osteoclasts, and chondrocytes in TLR4-dependent manner, inducing proinflammatory cytokines and chemokines including, IL-6, IL-8, KC, and MCP-1 (6-8). In osteoarthritic chondrocytes, S100A8 and A9 also promoted expression of matrix metalloproteinases (MMP-1, -3, -9, and -13) potentially affecting to cartilage breakdown (8). Human S100A8 is 93 amino acids (aa) in length. It contains two EF-hand motifs (aa 12-47 and aa 46-81) and one high-affinity Ca2+ binding site (aa 59-70). There may be one splice form that shows a 15 aa substitution for the C-terminal 14 amino acids. Although mouse S100A8 is cleaved by MMP‑2 after Asn21, it is unclear if human S100A8 is susceptible to the same cleavage. Full-length human S100A8 is 57% and 61% identical to mouse and rat S100A8, respectively (9).
- Averill, M.M. et al. (2012) Arterioscler. Thromb. Vasc. Biol. 32:223.
- Vogl, T. et al. (2012) Int. J. Mol. Sci. 13:2893
- Siegenthaler, G. et al. (1997) J. Biol. Chem. 272:9371.
- Sunahori, K. et al. (2006) Arthritis Res. Ther. 8:R69.
- Volz, H.C. et al. (2012) Basic Res. Cardiol. 107:250
- Chakraborty D. et al. (2017) Front Immunol. 8:1493
- Grevers L.C. Arthritis Rheum. 63:1365
- Schelbergen R.F. Arthritis Rheum. 64:1477
- Odink, K. et al. (1987) Nature 330:80
No product specific FAQs exist for this product, however you mayView all Proteins and Enzyme FAQs
Reviews for Recombinant Human S100A8 Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human S100A8 Protein, CF and earn rewards!
Have you used Recombinant Human S100A8 Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image